Literature DB >> 22226838

The carboxy-terminal third of dystrophin enhances actin binding activity.

Davin M Henderson1, Ava Yun Lin, David D Thomas, James M Ervasti.   

Abstract

Dystrophin is an actin binding protein that is thought to stabilize the cardiac and skeletal muscle cell membranes during contraction. Here, we investigated the contributions of each dystrophin domain to actin binding function. Cosedimentation assays and pyrene-actin fluorescence experiments confirmed that a fragment spanning two-thirds of the dystrophin molecule [from N-terminal actin binding domain (ABD) 1 through ABD2] bound actin filaments with high affinity and protected filaments from forced depolymerization, but was less effective in both assays than full-length dystrophin. While a construct encoding the C-terminal third of dystrophin displayed no specific actin binding activity or competition with full-length dystrophin, our data show that it confers an unexpected regulation of actin binding by the N-terminal two-thirds of dystrophin when present in cis. Time-resolved phosphorescence anisotropy experiments demonstrated that the presence of the C-terminal third of dystrophin in cis also influences actin interaction by restricting actin rotational amplitude. We propose that the C-terminal region of dystrophin allosterically stabilizes an optimal actin binding conformation of dystrophin.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226838      PMCID: PMC3273627          DOI: 10.1016/j.jmb.2011.12.040

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  41 in total

1.  The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.

Authors:  S Rentschler; H Linn; K Deininger; M T Bedford; X Espanel; M Sudol
Journal:  Biol Chem       Date:  1999-04       Impact factor: 3.915

Review 2.  ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins.

Authors:  C P Ponting; D J Blake; K E Davies; J Kendrick-Jones; S J Winder
Journal:  Trends Biochem Sci       Date:  1996-01       Impact factor: 13.807

3.  Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.

Authors:  Michele R Stone; Andrea O'Neill; Dawn Catino; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

4.  Cofilin increases the torsional flexibility and dynamics of actin filaments.

Authors:  Ewa Prochniewicz; Neal Janson; David D Thomas; Enrique M De la Cruz
Journal:  J Mol Biol       Date:  2005-09-26       Impact factor: 5.469

5.  Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle.

Authors:  Laurin M Hanft; Inna N Rybakova; Jitandrakumar R Patel; Jill A Rafael-Fortney; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

6.  Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association.

Authors:  I N Rybakova; J M Ervasti
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

7.  Dystrophin binding to nonmuscle actin.

Authors:  B A Renley; I N Rybakova; K J Amann; J M Ervasti
Journal:  Cell Motil Cytoskeleton       Date:  1998

8.  A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction.

Authors:  K J Amann; B A Renley; J M Ervasti
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

9.  Dystrophin and utrophin bind actin through distinct modes of contact.

Authors:  Inna N Rybakova; Jill L Humston; Kevin J Sonnemann; James M Ervasti
Journal:  J Biol Chem       Date:  2006-02-13       Impact factor: 5.157

10.  A new model for the interaction of dystrophin with F-actin.

Authors:  I N Rybakova; K J Amann; J M Ervasti
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

View more
  9 in total

1.  Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design.

Authors:  Ava Yun Lin; Ewa Prochniewicz; Davin M Henderson; Bin Li; James M Ervasti; David D Thomas
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

2.  Muscle lim protein isoform negatively regulates striated muscle actin dynamics and differentiation.

Authors:  Elizabeth Vafiadaki; Demetrios A Arvanitis; Vasiliki Papalouka; Gerasimos Terzis; Theodoros I Roumeliotis; Konstantinos Spengos; Spiros D Garbis; Panagiota Manta; Evangelia G Kranias; Despina Sanoudou
Journal:  FEBS J       Date:  2014-06-11       Impact factor: 5.542

3.  Electron microscopy and 3D reconstruction reveals filamin Ig domain binding to F-actin.

Authors:  Worawit Suphamungmee; Fumihiko Nakamura; John H Hartwig; William Lehman
Journal:  J Mol Biol       Date:  2012-10-04       Impact factor: 5.469

4.  The ZZ domain of dystrophin in DMD: making sense of missense mutations.

Authors:  Adeline Vulin; Nicolas Wein; Dana M Strandjord; Eric K Johnson; Andrew R Findlay; Baijayanta Maiti; Michael T Howard; Yuuki J Kaminoh; Laura E Taylor; Tabatha R Simmons; Will C Ray; Federica Montanaro; Jim M Ervasti; Kevin M Flanigan
Journal:  Hum Mutat       Date:  2013-12-02       Impact factor: 4.878

5.  Dystrophin quantification: Biological and translational research implications.

Authors:  Karen Anthony; Virginia Arechavala-Gomeza; Laura E Taylor; Adeline Vulin; Yuuki Kaminoh; Silvia Torelli; Lucy Feng; Narinder Janghra; Gisèle Bonne; Maud Beuvin; Rita Barresi; Matt Henderson; Steven Laval; Afrodite Lourbakos; Giles Campion; Volker Straub; Thomas Voit; Caroline A Sewry; Jennifer E Morgan; Kevin M Flanigan; Francesco Muntoni
Journal:  Neurology       Date:  2014-10-29       Impact factor: 9.910

6.  Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.

Authors:  Sandra Murphy; Margit Zweyer; Rustam R Mundegar; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  Proteomes       Date:  2015-09-16

7.  Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle.

Authors:  John T Olthoff; Angus Lindsay; Reem Abo-Zahrah; Kristen A Baltgalvis; Xiaobai Patrinostro; Joseph J Belanto; Dae-Yeul Yu; Benjamin J Perrin; Daniel J Garry; George G Rodney; Dawn A Lowe; James M Ervasti
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

Review 8.  Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine.

Authors:  Domenico D'Amario; Aoife Gowran; Francesco Canonico; Elisa Castiglioni; Davide Rovina; Rosaria Santoro; Pietro Spinelli; Rachele Adorisio; Antonio Amodeo; Gianluca Lorenzo Perrucci; Josip A Borovac; Giulio Pompilio; Filippo Crea
Journal:  J Clin Med       Date:  2018-09-19       Impact factor: 4.241

9.  Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.

Authors:  Nicolas Wein; Adeline Vulin; Maria S Falzarano; Christina Al-Khalili Szigyarto; Baijayanta Maiti; Andrew Findlay; Kristin N Heller; Mathias Uhlén; Baskar Bakthavachalu; Sonia Messina; Giuseppe Vita; Chiara Passarelli; Simona Brioschi; Matteo Bovolenta; Marcella Neri; Francesca Gualandi; Steve D Wilton; Louise R Rodino-Klapac; Lin Yang; Diane M Dunn; Daniel R Schoenberg; Robert B Weiss; Michael T Howard; Alessandra Ferlini; Kevin M Flanigan
Journal:  Nat Med       Date:  2014-08-10       Impact factor: 53.440

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.